2-methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo(1,2-alpha)pyrazin-3-one,
6-(4-methoxyphenyl)imidazo(1,2-a)pyrazin-3(7H)-one,
MCLA,
128322-44-1,
6-(4-Methoxyphenyl)-2-methylimidazo[1,2-a]pyrazin-3(7H)-one hydrochloride,
MCLA,
MCLA hydrochloride,
Cypridina Luciferin methoxy-analogue,
6-(4-Methoxyphenyl)-2-methyl-3,7-dihydroimidazo[1,2-a]pyrazin-3(7H)-one hydrochloride,
2-Methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo[1,2-a]pyrazin-3-one Hydrochloride,
2-Methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo(1,2-a)pyrazin-3-one hydrochloride,
MCLA[ChemiluminescenceReagent],
CHEMBL545463,
SCHEMBL2372566,
CTK3J8300,
DTXSID40585003,
MCLA [Chemiluminescence Reagent],
5412AA,
ANW-42654,
MFCD00144728,
AKOS016010214,
CS-8087,
HY-W013275,
RTR-003994,
KS-000016A2,
AK112672,
AX8137272,
TR-003994,
FT-0628173,
322M441,
C-56542,
J-005593,
2-methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo-[1,2-a]-pyrazin-3-one-hydrochloride,
2-Methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo[1,2-a]pyrazin-3(7H)-one hydrochloride,
6-(4-Methoxyphenyl)-2-methyl-3,7-dihydroimidazo[1,2-a]pyrazin-3-one Hydrochloride,
6-(4-Methoxyphenyl)-2-methylimidazo[1,2-a]pyrazin-3(7H)-one--hydrogen chloride (1/1),
6-(4-Methoxyphenyl)-2-methyl-3,7-dihydroimidazo[1,2-a]pyrazin-3(7H)-one hydrochloride, suitable for chemiluminescence, >=98.0% (HPLC),
C14H14ClN3O2,
KGMPQNFFCUDXSO-UHFFFAOYSA-N,
A5309,
A16944,